4.7 Article

Imaging mass spectrometry of myxoid sarcomas identifies proteins and lipids specific to tumour type and grade, and reveals biochemical intratumour heterogeneity

期刊

JOURNAL OF PATHOLOGY
卷 222, 期 4, 页码 400-409

出版社

WILEY-BLACKWELL
DOI: 10.1002/path.2771

关键词

myxofibrosarcoma; myxoid liposarcoma; myxoid; imaging mass spectrometry; clonal selection; tumour progression

资金

  1. Netherlands Organization for Scientific Research [ZonMw] [935-19-026]
  2. ZonMW [920-03-403]

向作者/读者索取更多资源

Myxofibrosarcoma and myxoid liposarcomas are relatively common soft tissue tumours that are characterized by their so-called myxoid extracellular matrix and have to some extent overlap in histology. The exact composition and potential role of their myxoid extracellular matrix are insufficiently understood. To gain more insight into the biomolecular content of these tumours, we have studied 40 well-documented myxofibrosarcoma and myxoid liposarcoma cases using imaging mass spectrometry. This technique provides a multiplex biomolecular imaging analysis of the tissue, spanning multiple molecular domains and without a priori knowledge of the tissue's biomolecular content. We have developed experimental protocols for analysing the peptide, protein, and lipid content of myxofibrosarcoma and myxoid liposarcomas, and have detected proteins and lipids that are tumour-type and tumour-grade specific. In particular, lipid changes observed in myxoid liposarcomas could be related to pathways known to be affected during tumour progression. Unsupervised clustering of the biomolecular signatures was able to classify myxofibrosarcoma and myxoid liposarcomas according to tumour type and tumour grade. Closer examination of histologically similar regions in the tissues revealed intratumour heterogeneity, which was a consistent feature in each of the myxofibrosarcomas studied. In intermediate-grade myxofibrosarcoma, it was found that single tissue sections could contain regions with biomolecular profiles similar to high-grade and low-grade tumours, and that these regions were associated with the tumour's nodular structure, thus supporting a concept of tumour progression through clonal selection. Copyright (C) 2010 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Pathology

Co-existence of lung carcinoma metastasis and enchondroma in the femur of a patient with Ollier disease

Xudong Wang, Xiaohui Zhang, Wenling Pan, Yuedong Han, Yanwei Li, Haibin Sun, Pancras C. W. Hogendoorn, Hong Cheng

Summary: The metastasis of lung squamous cell carcinoma to an enchondroma in the femur of a patient with Ollier disease is an extremely rare occurrence. Thorough clinical and radiological information is crucial for accurate diagnosis, while immunohistochemistry can be used to confirm the difference in lineage.

VIRCHOWS ARCHIV (2021)

Article Pathology

Spectrum of histiocytic neoplasms associated with diverse haematological malignancies bearing the same oncogenic mutation

Paul G. Kemps, Konnie M. Hebeda, Steven T. Pals, Robert M. Verdijk, King H. Lam, Annette H. Bruggink, Heleen S. de Lil, Bart Ruiterkamp, Koen de Heer, Jan A. M. van Laar, Peter J. M. Valk, Pim Mutsaers, Mark-David Levin, Pancras C. W. Hogendoorn, Astrid G. S. van Halteren

Summary: Research has found associations between histiocytic disorders and additional hematological malignancies with the same genetic alterations, indicating a common hematopoietic cell-of-origin in these patients. This highlights the importance of adequate staging, molecular analysis, and long-term follow-up of all histiocytosis patients.

JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2021)

Article Pathology

The adapter protein Myd88 plays an important role in limiting mycobacterial growth in a zebrafish model for tuberculosis

Rohola Hosseini, Gerda E. M. Lamers, Erik Bos, Pancras C. W. Hogendoorn, Abraham J. Koster, Annemarie H. Meijer, Herman P. Spaink, Marcel J. M. Schaaf

Summary: The study used zebrafish larvae infected with Mycobacterium marinum as an animal model for tuberculosis. The results showed that Myd88 deficiency led to more compact granuloma structures and a reduced number of leukocytes. Additionally, the majority of bacteria in the Myd88 mutant were located extracellularly, while most bacteria in the wild type were intracellular.

VIRCHOWS ARCHIV (2021)

Article Cell Biology

NTRK fusions are extremely rare in bone tumours

Suk Wai Lam, Inge H. Briaire-de Bruijn, Tom van Wezel, Arjen H. G. Cleven, Pancras C. W. Hogendoorn, Anne-Marie Cleton-Jansen, Judith V. M. G. Bovee

Summary: This study aimed to investigate the frequency of NTRK fusions in bone tumors, and the results showed that the likelihood of finding an NTRK fusion in bone tumors is extremely low.

HISTOPATHOLOGY (2021)

Article Hematology

ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition

Paul G. Kemps, Jennifer Picarsic, Benjamin H. Durham, Zofia Helias-Rodzewicz, Laura Hiemcke-Jiwa, Cor van den Bos, Marianne D. van de Wetering, Carel J. M. van Noesel, Jan A. M. van Laar, Robert M. Verdijk, Uta E. Flucke, Pancras C. W. Hogendoorn, F. J. Sherida H. Woei-A-Jin, Raf Sciot, Andreas Beilken, Friedrich Feuerhake, Martin Ebinger, Robert Mohle, Falko Fend, Antje Bornemann, Verena Wiegering, Karen Ernestus, Tina Mery, Olga Gryniewicz-Kwiatkowska, Bozenna Dembowska-Baginska, Dmitry A. Evseev, Vsevolod Potapenko, Vadim V. Baykov, Stefania Gaspari, Sabrina Rossi, Marco Gessi, Gianpiero Tamburrini, Sebastien Heritier, Jean Donadieu, Jacinthe Bonneau-Lagacherie, Claire Lamaison, Laure Farnault, Sylvie Fraitag, Marie-Laure Jullie, Julien Haroche, Matthew Collin, Jackie Allotey, Majid Madni, Kerry Turner, Susan Picton, Pasquale M. Barbaro, Alysa Poulin, Ingrid S. Tam, Dina El Demellawy, Brianna Empringham, James A. Whitlock, Aditya Raghunathan, Amy A. Swanson, Mariko Suchi, Jon M. Brandt, Nabeel R. Yaseen, Joanna L. Weinstein, Irem Eldem, Bryan A. Sisk, Vaishnavi Sridhar, Mandy Atkinson, Lucas R. Massoth, Jason L. Hornick, Sanda Alexandrescu, Kee Kiat Yeo, Kseniya Petrova-Drus, Stephen Z. Peeke, Laura S. Munoz-Arcos, Daniel G. Leino, David D. Grier, Robert Lorsbach, Somak Roy, Ashish R. Kumar, Shipra Garg, Nishant Tiwari, Kristian T. Schafernak, Michael M. Henry, Astrid G. S. van Halteren, Oussama Abla, Eli L. Diamond, Jean-Francois Emile

Summary: ALK-positive histiocytosis is a rare and poorly characterized subtype of histiocytic neoplasm. This study provides the largest analysis of ALK-positive histiocytosis to date, describing the clinicopathologic and molecular characteristics of 39 cases. The study also highlights the robust responses observed in patients treated with ALK inhibition, particularly those with neurologic involvement.
Article Biochemistry & Molecular Biology

Mutations in the heparan sulfate backbone elongating enzymes EXT1 and EXT2 have no major effect on endothelial glycocalyx and the glomerular filtration barrier

Ramzi Khalil, Margien G. S. Boels, Palga Group, Bernard M. van den Berg, Jan A. Bruijn, Ton J. Rabelink, Pancras C. W. Hogendoorn, Hans J. Baelde

Summary: This study investigates the effect of heterozygous germline mutations in the EXT1 and EXT2 genes on the glomerular barrier function and the endothelial glycocalyx in humans. The results show that these mutations do not lead to (micro)albuminuria, specific renal phenotype or changes to the endothelial glycocalyx in humans. These findings contribute to the understanding of the role of EXT1 and EXT2 genes in pathophysiology.

MOLECULAR GENETICS AND GENOMICS (2022)

Article Pathology

Clinicopathologic and molecular features of denosumab-treated giant cell tumour of bone (GCTB): Analysis of 21 cases

Li Yang, Hongjuan Zhang, Xiaohui Zhang, Yongqiang Tang, Zhigang Wu, Yingmei Wang, Hai Huang, Xin Fu, Jiayan Liu, Pancras C. W. Hogendoorn, Hong Cheng

Summary: Denosumab-treated GCTB exhibits histological changes such as depletion of giant cells and intralesional bone deposition, which may lead to diagnostic difficulties. The post-therapy tumors have a similar mutation profile to classic GCTB but significantly differ morphologically. Awareness of the features of DT-GCTB and conducting immunohistochemical and molecular studies for histone H3 mutations are important in its assessment.

ANNALS OF DIAGNOSTIC PATHOLOGY (2022)

Article Oncology

High-Mannose N-Glycans as Malignant Progression Markers in Early-Stage Colorectal Cancer

Fanny Boyaval, Hans Dalebout, Rene Van Zeijl, Wenjun Wang, Arantza Farina-Sarasqueta, Guinevere S. M. Lageveen-Kammeijer, Jurjen J. Boonstra, Liam A. McDonnell, Manfred Wuhrer, Hans Morreau, Bram Heijs

Summary: This study investigates the changes in sugar molecules during the progression of colorectal cancer (CRC) and finds that these sugar signatures can clearly differentiate different stages of CRC progression, especially between pre-cancerous and cancerous tissue. The study also observes the spreading of glycosylation signatures into the tumor microenvironment.

CANCERS (2022)

Article Oncology

Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial)

David J. Barnes, Peter Dutton, Oyvind Bruland, Hans Gelderblom, Ade Faleti, Claudia Buhnemann, Annemiek van Maldegem, Hannah Johnson, Lisa Poulton, Sharon Love, Gesa Tiemeier, Els van Beelen, Karin Herbschleb, Caroline Haddon, Lucinda Billingham, Kevin Bradley, Stefano Ferrari, Emanuela Palmerini, Piero Picci, Uta Dirksen, Sandra J. Strauss, Pancras C. W. Hogendoorn, Emmeline Buddingh, Jean-Yves Blay, Anne Marie Cleton-Jansen, Andrew Bassim Hassan

Summary: This study reports a Bayesian designed phase II trial that investigates the efficacy of liposomal MTP-PE alone or in combination with ifosfamide in patients with metastatic and/or recurrent osteosarcoma. Despite poor recruitment and no objective responses, the study demonstrates the feasibility of the Bayesian design and the collection of tissue and serum samples for further analysis. Further investigation of liposomal MTP-PE in metastatic osteosarcoma is warranted.

BMC CANCER (2022)

Article Oncology

Histone Deacetylase Inhibitors as a Therapeutic Strategy to Eliminate Neoplastic Stromal Cells from Giant Cell Tumors of Bone

Sanne Venneker, Robin van Eenige, Alwine B. Kruisselbrink, Ieva Palubeckaite, Alice E. Taliento, Inge H. Briaire-de Bruijn, Pancras C. W. Hogendoorn, Michiel A. J. van de Sande, Hans Gelderblom, Hailiang Mei, Judith V. M. G. Bovee, Karoly Szuhai

Summary: Giant cell tumor of bone (GCTB) is a bone neoplasm characterized by mutated neoplastic stromal cells. This study investigated the potential of histone deacetylase (HDAC) inhibitors as a therapeutic strategy to eliminate these neoplastic cells. The findings suggest that HDAC inhibition may improve the quality of life for GCTB patients who require life-long treatment.

CANCERS (2022)

Review Oncology

Brown Tumour in Chronic Kidney Disease: Revisiting an Old Disease with a New Perspective

Djoko Santoso, Mochammad Thaha, Maulana A. Empitu, Ika Nindya Kadariswantiningsih, Satriyo Dwi Suryantoro, Mutiara Rizki Haryati, Decsa Medika Hertanto, Dana Pramudya, Siprianus Ugroseno Yudho Bintoro, Nasronudin Nasronudin, Mochamad Yusuf Alsagaff, Hendri Susilo, Citrawati Dyah Kencono Wungu, Nicolaas C. Budhiparama, Pancras C. W. Hogendoorn

Summary: Osteitis fibrosa cystica (OFC) and Brown Tumours are rare bone lesions associated with chronic kidney disease. The mechanism of these conditions is not well understood, but recent literature suggests that factors such as overactivation of the renin-angiotensin-aldosterone system and chronic inflammation may contribute to their occurrence through osteoclast activation. In addition, hotspot KRAS mutations have been identified in these lesions, placing them in the spectrum of RAS-MAPK-driven neoplasms. Risk factors for OFC and Brown Tumours include age, gender, comorbidities, and certain medications. Diagnosis involves clinical symptoms of chronic bone pain and laboratory findings of hyperparathyroidism, as well as radiological imaging and histological examination.

CANCERS (2023)

Article Physiology

Transmembrane protein 14A protects glomerular filtration barrier integrity

Ramzi Khalil, Josephine D. D. Bonnemaijer, Reinhold Kreutz, Herman P. Spaink, Pancras C. W. Hogendoorn, Hans J. Baelde

Summary: Transmembrane protein 14A (TMEM14A) is an important protein involved in maintaining the integrity of the glomerular filtration barrier. It suppresses Bax-mediated apoptosis and its expression is increased in proteinuric renal diseases.

PHYSIOLOGICAL REPORTS (2023)

Review Immunology

Immunological factors linked to geographical variation in vaccine responses

Marloes M. A. R. van Dorst, Jeremia J. Pyuza, Gyaviira Nkurunungi, Vesla I. Kullaya, Hermelijn H. Smits, Pancras C. W. Hogendoorn, Linda J. Wammes, Bart Everts, Alison M. Elliott, Simon P. Jochems, Maria Yazdanbakhsh

Summary: There is considerable variation in efficacy of vaccines across populations and geographical regions, which is influenced by multiple environmental factors. Current interventions targeting these factors have had variable success, highlighting the need for a better understanding of the immunological mechanisms involved in vaccine responses.

NATURE REVIEWS IMMUNOLOGY (2023)

Meeting Abstract Oncology

Alk plus Histiocytosis: A new Clinicopathologic Spectrum highlighting Neurologic Involvement and Responses to Alk Inhibition

Paul Kemps, Jennifer Picarsic, Benjamin H. Durham, Zofia Helias-Rodzewicz, Laura Hiemcke-Jiwa, Cor van den Bos, Marianne D. van Dewetering, Carel J. M. van Noesel, Pancras C. W. Hogendoorn, F. J. Sherida H. Woei-A-Jin, Raf Sciot, Andreas Beilken, Friedrich Feuerhake, Martin Ebinger, Robert Mohle, Falko Fend, Antje Bornemann, Verena Wiegering, Karen Ernestus, Tina Mery, Olga Gryniewicz-Kwiatkowska, Bozenna Dembowska-Baginska, Dmitry A. Evseev, Vsevolod Potapenko, Vadim V. Baykov, Stefania Gaspari, Sabrina Rossi, Marco Gessi, Gianpiero Tamburrini, Sebastien Heritier, Jacinthe Bonneau-Lagacherie, Claire Lamaison, Laure Farnault, Sylvie Fraitag, Jean Donadieu, Julien Haroche, Matthew Collin, Jackie Allotey, Majid Madni, Kerry Turner, Susan Picton, Pasquale M. Barbaro, Dina El Demellawy, Brianna Empringham, James A. Whitlock, Aditya Raghunathan, Amy A. Swanson, Mariko Suchi, Jon M. Brandt, Nabeel R. Yaseen, Joanna L. Weinstein, Irem Eldem, Bryan A. Sisk, Vaishnavi Sridha, Mandy Atkinson, Lucas R. Massoth, Jason L. Hornick, Sanda Alexandrescu, Kee Kiat Yeo, Kseniya Petrova-Drus, Stephen Z. Peeke, Laura S. Munoz-Arcos, Daniel G. Leino, David D. Grier, Robert Lorsbach, Somak Roy, Ashish R. Kumar, Shipra Garg, Nishant Tiwari, Kristian T. Schafernak, Michael M. Henry, Astrid G. S. van Halteren, Oussama Abla, Eli L. Diamond, Jean-Francois Emile

PEDIATRIC BLOOD & CANCER (2022)

Review Medicine, General & Internal

Non-Hodgkin lymphoma of bone of the femur and humerus: a case report and review of the literature

Alex Mremi, Jeremia J. Pyuza, Bilal Ahmad, Alice A. Andongolile, Adnan Sadiq, James J. Yahaya, Karoly Szuhai, Pancras C. W. Hogendoorn

Summary: Primary non-Hodgkin lymphoma of bone is a rare neoplasm composed of malignant lymphoid cells, and delay in diagnosis and treatment can significantly impact patient prognosis. A case study reported a 13-year-old male with this condition, who unfortunately passed away shortly after diagnosis due to the COVID-19 outbreak, highlighting the importance of timely follow-up and treatment for patients with this disease.

OXFORD MEDICAL CASE REPORTS (2021)

暂无数据